General Electric Company (GE Aerospace) - Q2 2024 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2024. Following the completion of the separation of GE Vernova on April 2, 2024, the Company now operates as GE Aerospace. Historical results for GE Vernova and GE HealthCare are reported as discontinued operations. The Company operates through two reportable segments: Commercial Engines & Services and Defense & Propulsion Technologies.
Key Financial Metrics
| Metric | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Total Revenues | $9.1 billion | $8.8 billion | $18.0 billion | $16.6 billion |
| Continuing EPS (Diluted) | $1.20 | $1.09 | $2.78 | $7.06 |
| Adjusted EPS (Non-GAAP) | $1.20 | $0.74 | $2.13 | $1.37 |
| Operating Profit (Non-GAAP) | $1.9 billion | $1.4 billion | $3.4 billion | $2.6 billion |
| Operating Profit Margin (Non-GAAP) | 23.1% | 17.5% | 21.1% | 17.6% |
| Cash Flow from Operations (6mo) | $2.6 billion | $1.6 billion | - | - |
| Free Cash Flow (6mo, Non-GAAP) | $2.8 billion | $1.8 billion | - | - |
| Total Borrowings | $19.7 billion | - | - | - |
| Cash & Equivalents | $12.1 billion | - | - | - |
Material Changes vs. Prior Period
- Revenue Growth: Q2 revenues increased 4% year-over-year, driven by a 13% increase in Services revenues (due to higher shop visit volume and pricing) which offset a 14% decline in Equipment revenues (due to lower engine deliveries).
- Earnings Volatility: GAAP earnings for the six months ended June 30, 2024, decreased significantly compared to 2023. This was primarily due to a $6.0 billion reduction in gains on retained and sold ownership interests (specifically GE HealthCare and AerCap), which were non-recurring in the prior year.
- Segment Performance:
- Commercial Engines & Services: Revenues up 7% and profit up 21% in Q2, driven by strong services demand and pricing.
- Defense & Propulsion Technologies: Revenues up 1% and profit up 71% in Q2, driven by growth in Propulsion & Additive Technologies and higher pricing.
- Remaining Performance Obligation (RPO): Increased to $159.8 billion as of June 30, 2024, a 4% increase from year-end 2023, indicating a robust order backlog.
Guidance, Outlook, and Risks
- Capital Allocation: The Board authorized a new $15.0 billion share repurchase program. The Company repurchased $1.9 billion of stock in Q2 2024. Management intends to return a majority of free cash flow to shareholders via dividends and buybacks.
- Outlook: Management expects global commercial departures to grow at a high-single-digit rate in 2024. Defense budgets are expected to grow in the low-to-mid single digits.
- Supply Chain: Global material availability and supplier delivery performance continue to cause disruptions, impacting equipment production and deliveries. The Company is investing in facilities and supply chain to mitigate these issues.
- Key Risks:
- GE Vernova Guarantees: GE Aerospace retains certain credit support obligations for GE Vernova with an estimated RPO exposure of $29.0 billion. GE Vernova is obligated to indemnify GE Aerospace for any payments made.
- Bank BPH Litigation: Ongoing litigation regarding foreign currency mortgage loans in Poland. Estimated total losses are $2.47 billion as of June 30, 2024.
- Insurance Run-off: Continued capital contributions may be required for run-off insurance operations, though the final contribution of $1.8 billion was made in Q1 2024.
Investor Verification Checklist
- Discontinued Operations Impact: Verify the extent to which GAAP earnings are depressed by the absence of one-time gains from GE HealthCare and AerCap sales present in the prior year.
- Supply Chain Constraints: Monitor updates on material availability and supplier performance, as these directly impact equipment delivery volumes and revenue recognition.
- Share Repurchase Execution: Track the pace of the new $15 billion buyback program and its impact on share count and EPS.
- GE Vernova Indemnification: Review the status of the transition of credit support guarantees and any potential exposure to indemnification claims.
- Bank BPH Exposure: Confirm the stability of the $2.47 billion loss estimate for the Polish mortgage litigation and any potential for future capital calls.